Decidua basalis-derived mesenchymal stem cells differentiate into dopamine neuron-like cells

LU Guohui,JIANG Chunmei,HONG Tao,ZHANG Shizhong
DOI: https://doi.org/10.3969/j.issn.1671-2897.2013.04.009
2013-01-01
Abstract:Objective To explore the differentiation potential of human placental decidua basalis-derived mesenchymal stem cells(DBMSCs) into dopamine neuron-like cells in vitro,and optimize theinduction protocols.Methods DBMSCs were isolated and cultured in vitro,and the cells were co-cultured with epidermal growth factor(EGF)+human basic fibroblast growth factor(bFGF)+B27 and sonic hedgehog(SHH)+ fibroblast growth factor 8(FGF8)+forskolin+ brain-derived neurotrophic factor(BDNF) containing medium successively,and the whole induction process was divided into two stages;immunocytochemistry was performed to identify the expression of stem cell markers(nestin and CD133),mature neuron markers(neuronal-specific enolase,NSE),astroglial marker(glial fibrillary acidic protein,GFAP),and dopamine neuron specific marker(tyrosine hydroxylase,TH);Western blot analysis was performed to confirm the expression of TH protein of differentiated DBMSCs.High performance liquid chromatography coupled to electrochemical detection was performed to detect the dopamine secretion of pre-and post-differentiated DBMSCs.Results After the first stage induction,free-floating neurospheres appeared and were nestin-and CD133-positive staining.After the second stage induction,cells adopted a neural-like morphology and were NSE-,GFAP-,and TH-positive staining.Western blot showed the expression of TH protein and dopamine secretion level were significantly increased.Conclusion Depending on the differentiation potential towards dopamine neuron-like cells,DBMSCs can serve as a novel seed cell source for transplantation therapy of Parkinson's disease.
What problem does this paper attempt to address?